TME Pharma CEO outlines NOX-A12 partnering strategy and runway through Q2 2027

Sep 16, 2026 06:00 (39d ago)

Verifying

TME Pharma published CEO Diede van den Ouden’s message on strategy and NOX-A12 partnering.
Cost reductions extended TME Pharma’s financial runway into the second quarter of 2027.
TME Pharma is evaluating partners following its August 24, 2026 announcement.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.